Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer için istatistikler
Toplam ziyaret
views | |
---|---|
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer | 0 |
Aylık toplam ziyaret
views | |
---|---|
Ocak 2024 | 0 |
Şubat 2024 | 0 |
Mart 2024 | 0 |
Nisan 2024 | 0 |
Mayıs 2024 | 0 |
Haziran 2024 | 0 |
Temmuz 2024 | 0 |